Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression

Yang SY, Nguyen TT, Ung TT, Jung YD

Recepteur d'origine nantais (RON) is a receptor tyrosine kinase belonging to the subfamily of which c-MET is the prototype. Large epidemiologic studies have confirmed the strong association between RON and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma

Choe JY, Yun JY, Nam SJ, Kim JE

  • KMID: 2012050
  • Korean J Pathol.
  • 2012 Dec;46(6):515-522.
BACKGROUND: Activation of the c-Met pathway is involved in cancer progression and the prognosis. We aimed to identify any association of c-Met protein expression with a number of clinicopathologic variables...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-MET in Invasive Meningioma

Yun S, Koh JM, Lee KS, Seo AN, Nam KH, Choe G

BACKGROUND: Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of the c-Met Proteins in Malignant Skin Cancers

Lee YJ, Kim DH, Lee SH, Kim DW, Nam HS, Cho MK

BACKGROUND: The expression of c-Met is substantially elevated in most malignant human cancers. We therefore searched for c-Met expression and compared the expression level among malignant skin cancers. OBJECTIVE: The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of Hepatocyte Growth Factor/c-met by RT-PCR in Meningiomas

Kim NR, Chae YS, Lim WJ, Cho SJ

BACKGROUND: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An alternatively spliced form of Met receptor is tumorigenic

Lee JH, Gao CF, Lee CC, Kim MD, Vande Woude GF

  • KMID: 1098091
  • Exp Mol Med.
  • 2006 Oct;38(5):565-573.
The Met tyrosine kinase receptor is a widely expressed molecule, which mediates pleiotropic cellular responses following activation by its ligand, hepatocyte growth factor/scatter factor (HGF/SF). Previously, one of the authors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of the c-Met, p53 and Ki-67 Proteins in Astrocytic Tumors

Cho BH, Cho BM, Ahn HK, Lim WJ, Park SH, Oh SM

  • KMID: 1955777
  • J Korean Neurosurg Soc.
  • 2003 Sep;34(3):202-206.
OBJECTIVE: The pathologic diagnosis of the astrocytoma has been primarily based on the histologic grading, however, there are some discrepancies among the pathologists on the tumor grading. Met protein, known...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A putative pH-dependent nuclear localization signal in the juxtamembrane region of c-Met

Chaudhary , Cho MG, Nguyen TT, Park KS, Kwon MH, Lee JH

The C-terminal fragment of the c-Met receptor tyrosine kinase is present in the nuclei of some cells irrespective of ligand stimulation, but the responsible nuclear localization signal (NLS) has not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Study of the Expression of E-cadherin, beta-catenin, and c-Met in Gastric Adenocarcinomas

Cho SJ, Kim MK, Shin BK, Min YK, Cho MY, Suh SO, Won NH, Chae YS

  • KMID: 2372348
  • J Korean Gastric Cancer Assoc.
  • 2001 Jun;1(2):92-99.
PURPOSE: E-cadherin is an adhesion molecule essential for tight connection between cells, forming the cadherin/catenin complex. Truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin, leading to the loss of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-met Gene in Thyroid Tumors

Cha HJ, Cho SJ, Yoo CW, Chang WY, Kang HJ, Joo SH, Park CH, Park CJ

  • KMID: 1896216
  • J Korean Surg Soc.
  • 2004 Oct;67(4):279-285.
PURPOSE: The hepatocyte growth factor, (HGF)/c-Met, pathway may play various roles in the carcinogenesis of various organs. HGF, a ligand for c-Met, is a pleiotrophic factor that was originally identified...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-erbB-2 and c-met Proteins in Gastric Adenoma and Adenocarcinoma

Lee SW, Kang SB, Kim YS, Nam SW, Lee DS, Lee HK, Han SW

  • KMID: 782837
  • Korean J Gastroenterol.
  • 2007 Mar;49(3):152-157.
BACKGROUND/AIMS: The aim of this study was to investigate the immunohistochemical overexpression of c-erbB-2 and c-met proteins according to the histopathological parameters such as grade of dysplasia, histological type, depth...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion

Kwak IH, Shin YH, Kim M, Cha HY, Nam HJ, Lee BS, Chaudhary , Pai KS, Lee JH

Aberrant activation of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, Met, is involved in the development and progression of many human cancers. In the cell-based screening assay, (-)epigallocatechin-3-gallate (EGCG)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line

Lee YY, Kim HP, Kang MJ, Cho BK, Han SW, Kim TY, Yi EC

  • KMID: 2154283
  • Exp Mol Med.
  • 2013 Nov;45(11):e64.
Lapatinib, a dual inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases, has shown promising results as a growth inhibitor of HER2-positive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatocyte Growth Factor and Kidney Disease

Park JS, Kim GH

  • KMID: 2252674
  • Korean J Nephrol.
  • 2011 Jul;30(4):359-367.
Hepatocyte growth factor (HGF), also known as scatter factor, was identified during the experimental attempts to explore a phantom factor acting as a trigger for liver regeneration after partial hepatecotmy....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Significance of p53, mTOR, c-Met, IGF-1R, and HSP70 Overexpression after the Resection of Hepatocellular Carcinoma

Kang GH, Lee BS, Lee ES, Kim SH, Lee HY, Kang DY

  • KMID: 1774532
  • Gut Liver.
  • 2014 Jan;8(1):79-87.
BACKGROUND/AIMS: The current study examines the expression of molecular biomarkers in hepatocellular carcinoma (HCC) and whether these findings correlate with the clinicopathologic features of the disease and patient survival. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells

Pei J, Chu T, Shao M, Teng J, Sha H, Gu A, Li R, Qian J, Mao W, Li Y, Han B

PURPOSE: c-Met and its ligand, hepatocyte growth factor (HGF), play a critical role in oncogenesis and metastatic progression. The aim of this study was to identify inhibited enzymogram and to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of HGF/c-Met in Serum-Starved ARPE-19 Cells

Jun EJ, Kim HS, Kim YH

PURPOSE: Hepatocyte growth factor (HGF) and its receptor (HGFR/c-Met) regulate motility, mitogenesis, and morphogenesis in a cell type-dependent fashion. We report the role of HGF and c-Met on stress-induced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expressions and Clinical Significances of c-met, c-erbB-2, COX-2, and IL-6 in the Biliary Tract Cancers

Joo HH, Song EY, Jin SH, Oh SH, Choi YK

  • KMID: 937932
  • Korean J Gastroenterol.
  • 2007 Dec;50(6):370-378.
BACKGROUND/AIMS: c-met, c-erbB-2, interleukin (IL)-6, and cyclooxygenase (COX)-2 expressions are considered to be implicated in the carcinogenesis and progression of cholangiocarcinoma, but the molecular pathogenesis of cholangiocarcinoma is still...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dimethylnitrosamine-Induced Liver Cirrhosis and Expression of Hepatocyte Growth Factor (HGF), its Receptor c-Met, and the Transforming Growth Factor (TGF)-beta1 in Sprague-Dawley Rats

Kim WH, Lee JH, Jin YM, Cho H, Park HL, Jung MK, Kwak YS, Han SU, Wang HJ, Lee KU, Kim MW

  • KMID: 2206400
  • J Korean Surg Soc.
  • 1998 Oct;55(4):453-468.
BACKGROUND: Liver fibrosis and cirrhosis are the ultimate histologic consequences of chronic liver damage. Efforts have been made to study the mechanisms of cirrhosis and to discover effective therapeutic strategies....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatocyte Growth Factor/c-Met Signaling in Regulating Urokinase Plasminogen Activator in Human Stomach Cancer: A Potential Therapeutic Target for Human Stomach Cancer

Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR

BACKGROUND: Up-regulation of the hepatocyte growth factor (HGF), its transmembrane tyrosine kinase receptor (c-Met), and urokinase type plasminogen activator (uPA), is associated with the development and metastasis of various...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr